This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-consensus-estimate: Archive
Nordea Bank (NRDBY) Upgraded to Buy: Here's Why
by Zacks Equity Research
Nordea Bank (NRDBY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NRDBYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Why Is Viking (VIK) Up 5.8% Since Last Earnings Report?
by Zacks Equity Research
Viking (VIK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
VIKPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Keysight (KEYS) Up 9.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Keysight (KEYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
KEYSPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MDTNegative Net Change QDELPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Toll Brothers (TOL) Up 6.6% Since Last Earnings Report?
by Zacks Equity Research
Toll Brothers (TOL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TOLPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Jack Henry (JKHY) Down 2.5% Since Last Earnings Report?
by Zacks Equity Research
Jack Henry (JKHY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
JKHYPositive Net Change SERVNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Costco (COST) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Costco (COST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
COSTNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Jabil (JBL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Jabil (JBL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JBLPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Wall Street Analysts Think Edgewise Therapeutics (EWTX) Could Surge 182%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Edgewise Therapeutics (EWTX) points to an 182% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
EWTXPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at an 81.3% upside potential for Bright Minds Biosciences Inc. (DRUG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
DRUGPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Darden Restaurants (DRI) Misses Q1 Earnings Estimates
by Zacks Equity Research
Darden Restaurants (DRI) delivered earnings and revenue surprises of -1.50% and +0.17%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
DRIPositive Net Change DPZPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
FactSet Research (FDS) Q4 Earnings Lag Estimates
by Zacks Equity Research
FactSet (FDS) delivered earnings and revenue surprises of -2.41% and +0.73%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
FDSPositive Net Change BYRNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sangoma Technologies Corporation (SANG) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Sangoma Technologies Corporation (SANG) delivered earnings and revenue surprises of +100.00% and +1.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SANGPositive Net Change PAYXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cracker Barrel Old Country Store (CBRL) Misses Q4 Earnings Estimates
by Zacks Equity Research
Cracker Barrel (CBRL) delivered earnings and revenue surprises of -5.13% and +1.33%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
CBRLPositive Net Change DRIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Why CrowdStrike (CRWD) Might be Well Poised for a Surge
by Zacks Equity Research
CrowdStrike Holdings (CRWD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CRWDPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Will Carnival (CCL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Carnival (CCL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CCLPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Jabil (JBL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Jabil (JBL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
JBLPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
All You Need to Know About Algorhythm Holdings, Inc. (RIME) Rating Upgrade to Buy
by Zacks Equity Research
Algorhythm Holdings, Inc. (RIME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RIMEPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
First Bancorp (FBNC) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
First Bancorp (FBNC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FBNCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Kezar Life Sciences (KZR) Rating Upgrade to Buy
by Zacks Equity Research
Kezar Life Sciences (KZR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
KZRNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Toast (TOST) Rating Upgrade to Buy
by Zacks Equity Research
Toast (TOST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TOSTPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Jackson Financial (JXN) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Jackson Financial (JXN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
JXNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Local Bounti (LOCL) Rating Upgrade to Buy
by Zacks Equity Research
Local Bounti (LOCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LOCLNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About American Lithium (AMLIF) Rating Upgrade to Buy
by Zacks Equity Research
American Lithium (AMLIF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AMLIFNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
GE HealthCare (GEHC) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
GE HealthCare (GEHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
GEHCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank